 PHILADELPHIA, March 25, 2021 GLOBE NEWSWIRE -- Passage Bio, Inc. NASDAQ: PASG, a genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous system disorders, today announced that management will participate in three upcoming virtual investor conferences in April: 